PRESS RELEASE published on 08/05/2024 at 10:32, 2 years ago Medios expands „Advanced Therapies“ field and appoints Dr. Andreas Schmiede as Vice President Medios AG strengthens activities in Advanced Therapies field, appoints Dr. Andreas Schmiede as Vice President. Focus on personalized medicine innovations and patient access to cutting-edge therapies Medios AG Advanced Therapies Personalized Medicine Dr. Andreas Schmiede Pharmaceutical Innovations
BRIEF published on 07/01/2024 at 09:37, 2 years 1 month ago “Hauptstadtkongress 2024”: Medios Hosts Symposium on 'Security of Supply' Healthcare System Medios AG Specialty Pharma Hauptstadtkongress 2024 Security Of Supply
BRIEF published on 07/01/2024 at 09:37, 2 years 1 month ago « Hauptstadtkongress 2024 » : Medios organise un symposium sur la « sécurité d'approvisionnement » Medios AG Pharmacie Spécialisée Congrès De La Hauptstadt 2024 Système De Soins De Santé Sécurité D'approvisionnement
PRESS RELEASE published on 07/01/2024 at 09:32, 2 years 1 month ago “Hauptstadtkongress 2024”: Medios hosts symposium on 'Security of supply” Medios AG participated in 'Hauptstadtkongress 2024', focusing on 'Security of supply'. Experts discussed challenges in patient care and the importance of cooperation in Specialty Pharma sector Healthcare System Medios AG Specialty Pharma Hauptstadtkongress 2024 Security Of Supply
BRIEF published on 06/20/2024 at 10:07, 2 years 1 month ago Successful Transfer of Medios AG Shares to Luxempart S.A. Investment Medios AG Share Sale Specialty Pharma Luxempart S.A.
BRIEF published on 06/20/2024 at 10:07, 2 years 1 month ago Transfert réussi des actions Medios AG à Luxempart SA Investissement Medios AG Vente D'actions Pharmacie Spécialisée Luxempart SA
PRESS RELEASE published on 06/20/2024 at 10:02, 2 years 1 month ago Medios AG: Successful sale of shares from Company founder Manfred Schneider to Luxempart S.A. Medios AG founder Manfred Schneider sells 14.9% of shares to Luxempart S.A., a Luxembourg investment company, marking a turning point in Medios' growth strategy Investment Medios AG Specialty Pharma Luxempart S.A. Manfred Schneider
BRIEF published on 06/07/2024 at 10:33, 2 years 2 months ago Hauck & Aufhäuser Initiates Coverage of Medios AG with Buy Recommendation and €23.00 Price Target Buy Recommendation Medios AG Specialty Pharma Hauck & Aufhäuser Price Target €23.00
BRIEF published on 06/07/2024 at 10:33, 2 years 2 months ago Hauck & Aufhäuser lance la couverture de Medios AG avec une recommandation d'achat et un objectif de prix de 23,00 € Medios AG Recommandation D'achat Pharmacie Spécialisée Hauck & Aufhäuser Objectif De Prix 23,00 €
PRESS RELEASE published on 06/07/2024 at 10:28, 2 years 2 months ago Hauck & Aufhäuser starts coverage of Medios AG with buy recommendation and price target of €23.00 Hauck & Aufhäuser initiates coverage of Medios AG with buy recommendation and €23.00 price target, a 55% upside potential from Xetra closing price on June 5, 2024. Medios AG, a leading Specialty Pharma provider in Europe, aims at expanding innovative therapies Buy Recommendation Medios AG Price Target Specialty Pharma Hauck & Aufhäuser
Published on 08/07/2026 at 23:15, 1 day 4 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 1 day 4 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 1 day 5 hours ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 1 day 5 hours ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/09/2026 at 00:01, 3 hours 41 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 08/08/2026 at 16:25, 11 hours 17 minutes ago Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 1 day 4 hours ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 1 day 8 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 1 day 8 hours ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:54, 1 day 8 hours ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 1 day 8 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 1 day 9 hours ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 1 day 9 hours ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 1 day 9 hours ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026